Havas Health & You (HH&Y) announced the appointment of Eric Weisberg as Global Chief Creative Officer for the quickly expanding network.

Ashfield Health, an agile global health marketing and communications network, announced the appointment of three new senior roles across the business.

Biopharma and life sciences companies strengthened their leadership teams and boards with these personnel appointments.

GSW named Andrew Schirmer as president, GSW-NY. Management says Schirmer will lead the agency’s New York office and drive strategic results for GSW’s vast roster of domestic and global healthcare clients.

Ashfield Advisory, an ecosystem of healthcare advisory and consulting businesses and part of UDG Healthcare plc., announced two senior leadership appointments.

Stuart Goldstein was hired as Chief Operating Officer at The Bloc. In the newly created role of COO, Goldstein is responsible for the execution of more than 4,500 projects per year across The Bloc’s U.S. client business. His duties include optimizing project management and identifying metrics to increase efficiency and profitability.

The Klick Group of Companies’ Chairman and CEO Leerom Segal today announced the arrival of Ryan Slipakoff as Chief Transformation Officer. Slipakoff brings a wealth of diverse expertise from across the healthcare and digital ecosystem to the newly created role. 

GSW, a Syneos Health agency and industry leader in healthcare advertising, named Andrew Schirmer as president, GSW-NY. Schirmer will lead the agency’s New York office and drive strategic results for GSW’s vast roster of domestic and global healthcare clients.

EVERSANA, a pioneer of next generation commercial services to the global life sciences industry, on May 6 announced key appointments across Europe to further strengthen the company’s worldwide market access and pricing solutions leadership position.

Roger Perlmutter will helm the drug discovery startup Eikon Therapeutics after the industry veteran and former president of Merck Research Laboratories departed the pharma giant at the end of 2020. California-based Eikon emerged from stealth mode with a $148 million Series A financing round.